The challenges for pharma and biotech are more diverse than ever. The growing and aging population and the increase in age-related and chronic diseases offer favorable conditions for growth. As therapies become more targeted, the development of new and innovative therapies requires significant resources. Public health policy continues to exert cost pressures, combined with demands for pharma-economic performance and outcomes-based pricing toward personalized medicine. Digital technologies, the Internet of Things, the digitization of sales, and new AI algorithms for demand management combined with agile processes are the challenges we face together with you.
The goal of this project was to avoid constant supply chain disruptions in order to secure growth and profitability targets.
Transformation of a traditional Pharma company into an agile Pharma Corporation able to master future global challenges.